San Francisco, CA – Dr. Chi Yang, the CEO of SynPep, a provider of custom peptide synthesis and antibody research products, was indicted by a federal grand jury on 13 counts of mail fraud and false statements for falsifying the purity levels of the company’s peptide products. The indictment claims that under Dr. Yang’s supervision, […]
Chalfont St Giles, UK and Philadelphia, PA – General Electric and MDS Pharma Services announced the availability of a new, automated in vitro micronucleus assay that incorporates GE Healthcare’s IN Cell 1000 and IN Cell 3000 high content analysis platforms. This automated imaging assay enables an accurate, early assessment of the potential genotoxicity of novel […]
Venlo, The Netherlands- QIAGEN NV has entered into a definitive merger agreement with Gentra Systems for $38 million in cash. Gentra, developer, manufacturer and supplier of non-solid phase nucleic acid purification products is focused on the niche market for large-scale blood samples of up to 10 ml. QIAGEN expects the transaction to contribute $6 million […]
PALO ALTO, Calif., Agilent Technologies Inc. (NYSE: A)announced that it has acquired privately held SynPro Corp., the owner of a contract manufacturing facility established to supply active pharmaceutical ingredients and provide related services. Financial details were not disclosed. Based on Agilent and industry estimates, the size of the combined RNA and DNA synthesis market is […]
SANTA CLARA, Calif.–Affymetrix Inc. (Nasdaq:AFFX) announced that Abbott Molecular, a division of Abbott, has obtained a non-exclusive, worldwide license to a number of Affymetrix patents that will allow it to manufacture and sell comparative genomic hybridization (CGH) microarrays, related readers and software in the research and diagnostics field. Details of the license were not disclosed.
FOSTER CITY, Calif & WASHINGTON–At the 2006 Annual Meeting of the American Association for Cancer Research, Applied Biosystems (NYSE:ABI), an Applera Corporation business, announced the commercial availability of 300 individual TaqMan(R) MicroRNA Assays (also known as miRNA assays) for human, mouse, and rat studies. MicroRNAs, one of the smallest entities in the human genome responsible […]
BOSTON–PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics,announced the acquisition of Agilix Corporation’s proprietary proteomics technology. Agilix has developed a powerful labeling technology using isobaric mass tags that allows for the simultaneous quantification of molecules, such as proteins, from multiple samples. This technology now brings quantitative proteomics to PerkinElmer customers […]
Boston, MA—PerkinElmer has acquired Agilix, a developer of labeling technology using isobaric mass tags for simultaneous quantification of molecules from multiple samples. “The Agilix multiplex protein labeling technology represents a breakthrough in quantitative proteomics. This leading-edge technology reduces the process workflow in proteomics analysis, and enables more accurate studies in protein expression kinetics and pharmacodynamics,” […]
FOSTER CITY, CA and AUSTIN, TX – Applied Biosystems Group (NYSE: ABI), an Applera Corporation business, announced that it has completed the previously announced acquisition of the Research Products Division of Ambion, Inc., a premium provider of innovative products for the study and analysis of ribonucleic acid (RNA), the central molecule used in gene expression […]
PITTSBURGH, Pa., and HAMBURG, Germany,– Cellomics, Inc., a business unit within the Fisher Biosciences group, and Evotec Technologies GmbH announced today that they have entered into a worldwide, non-exclusive patent license agreement. The agreement will provide Evotec Technologies with Cellomics’ core High Content Screening (HCS) patent portfolio, which includes both broad claims to HCS technology […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
